Schedule 13G ownership disclosure

AEON BIOPHARMA INC

Common · CUSIP: 00791X209

Event date: 2025-05-27

Filing-level shares
1,128,500.00
Percent of class
9.9%
  • Chernett Jorey

    Shares: 1,128,500.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001137439-25-000540
Form type
SCHEDULE 13G
Filer
AEON Biopharma, Inc.
CIK
CIK 1837607
Filed
May 30, 2025
Reporting period
May 27, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub